FMR LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-10 08:52 am Sale | 2021-12-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS | FMR LLC | 0 0.000% | -4,575,536 (Position Closed) | Filing |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS | FMR LLC | 4,575,536 11.060% | 4,251,667 (+1312.77%) | Filing |